![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 38, 35239-35242, September 21, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Catenin*
,
,
From the Dana-Farber Cancer Institute, Harvard Medical School,
Boston, Massachusetts 02115, the § Division of New Born
Medicine, Children's Hospital, Harvard Medical School, Boston,
Massachusetts 02115, and the ¶ Department of Biological Chemistry
and University of California Davis Cancer Center, University of
California at Davis, Sacramento, California 95817
The DF3/MUC1 mucin-like, transmembrane
glycoprotein is aberrantly overexpressed in most human carcinomas. The
MUC1 cytoplasmic domain interacts with the c-Src tyrosine kinase and
thereby increases binding of MUC1 and
-catenin. In the present work,
coimmunoprecipitation studies demonstrate that MUC1 associates
constitutively with the epidermal growth factor receptor (EGF-R) in
human ZR-75-1 breast carcinoma cells. Immunofluorescence studies show
that EGF-R and MUC1 associate at the cell membrane. We also show that
the activated EGF-R phosphorylates the MUC1 cytoplasmic tail on
tyrosine at a YEKV motif that functions as a binding site for the c-Src
SH2 domain. The results demonstrate that EGF-R-mediated phosphorylation of MUC1 induces binding of MUC1 to c-Src in cells. Moreover, in vitro and in vivo studies demonstrate that EGF-R
increases binding of MUC1 and
-catenin. These findings support a
novel role for EGF-R in regulating interactions of MUC1 with c-Src and
-catenin.
These authors contributed equally to this work.
To whom correspondence should be addressed: Adult
Oncology, Dana-Farber Cancer Institute, 44 Binney St., Boston, MA
02115. Tel.: 617-632-3141; Fax: 617-632-2934; E-mail:
donald_kufe@dfci.harvard.edu.
This article has been cited by other articles:
![]() |
Q. Shen, J. J. Rahn, J. Zhang, N. Gunasekera, X. Sun, A. R.E. Shaw, M. J. Hendzel, P. Hoffman, A. Bernier, and J. C. Hugh MUC1 Initiates Src-CrkL-Rac1/Cdc42-Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1 Mol. Cancer Res., April 1, 2008; 6(4): 555 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. K Gipson, T. Blalock, A. Tisdale, S. Spurr-Michaud, S. Allcorn, A. Stavreus-Evers, and K. Gemzell MUC16 Is Lost from the Uterodome (Pinopode) Surface of the Receptive Human Endometrium: In Vitro Evidence That MUC16 Is a Barrier to Trophoblast Adherence Biol Reprod, January 1, 2008; 78(1): 134 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawano, M. Ito, D. Raina, Z. Wu, J. Rosenblatt, D. Avigan, R. Stone, and D. Kufe MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells Cancer Res., December 15, 2007; 67(24): 11576 - 11584. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sangha and C. Butts L-BLP25: A Peptide Vaccine Strategy in Non Small Cell Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4652s - 4654s. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Leng, C. Cao, J. Ren, L. Huang, D. Chen, M. Ito, and D. Kufe Nuclear Import of the MUC1-C Oncoprotein Is Mediated by Nucleoporin Nup62 J. Biol. Chem., July 6, 2007; 282(27): 19321 - 19330. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siragusa, M. Zerilli, F. Iovino, M. G. Francipane, Y. Lombardo, L. Ricci-Vitiani, G. Di Gesu, M. Todaro, R. De Maria, and G. Stassi MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells Cancer Res., June 1, 2007; 67(11): 5522 - 5530. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wei, H. Xu, and D. Kufe Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene Cancer Res., February 15, 2007; 67(4): 1853 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, S. Kharbanda, and D. Kufe Mucin 1 Oncoprotein Blocks Hypoxia-inducible Factor 1{alpha} Activation in a Survival Response to Hypoxia J. Biol. Chem., January 5, 2007; 282(1): 257 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, D. Raina, W. Chen, G. Li, L. Huang, and D. Kufe MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling Mol. Cancer Res., November 1, 2006; 4(11): 873 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moniaux, W. M. Junker, A. P. Singh, A. M. Jones, and S. K. Batra Characterization of Human Mucin MUC17: COMPLETE CODING SEQUENCE AND ORGANIZATION J. Biol. Chem., August 18, 2006; 281(33): 23676 - 23685. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Funes, J. K. Miller, C. Lai, K. L. Carraway III, and C. Sweeney The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3 J. Biol. Chem., July 14, 2006; 281(28): 19310 - 19319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Thompson, K. Shanmugam, C. L. Hattrup, K. L. Kotlarczyk, A. Gutierrez, J. M. Bradley, P. Mukherjee, and S. J. Gendler Tyrosines in the MUC1 Cytoplasmic Tail Modulate Transcription via the Extracellular Signal-Regulated Kinase 1/2 and Nuclear Factor-{kappa}B Pathways Mol. Cancer Res., July 1, 2006; 4(7): 489 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kinlough, R. J. McMahan, P. A. Poland, J. B. Bruns, K. L. Harkleroad, R. J. Stremple, O. B. Kashlan, K. M. Weixel, O. A. Weisz, and R. P. Hughey Recycling of MUC1 Is Dependent on Its Palmitoylation J. Biol. Chem., April 28, 2006; 281(17): 12112 - 12122. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Huang, D. Chen, D. Liu, L. Yin, S. Kharbanda, and D. Kufe MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3{beta}-Mediated Phosphorylation and Degradation of {beta}-Catenin Cancer Res., November 15, 2005; 65(22): 10413 - 10422. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Levitin, A. Baruch, M. Weiss, K. Stiegman, M.-l. Hartmann, M. Yoeli-Lerner, R. Ziv, S. Zrihan-Licht, S. Shina, A. Gat, et al. A Novel Protein Derived from the MUC1 Gene by Alternative Splicing and Frameshifting J. Biol. Chem., March 18, 2005; 280(11): 10655 - 10663. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vasir, D. Avigan, Z. Wu, K. Crawford, S. Turnquist, J. Ren, and D. Kufe Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism J. Immunol., February 15, 2005; 174(4): 2376 - 2386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kinlough, P. A. Poland, J. B. Bruns, K. L. Harkleroad, and R. P. Hughey MUC1 Membrane Trafficking Is Modulated by Multiple Interactions J. Biol. Chem., December 17, 2004; 279(51): 53071 - 53077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. de Bono, S. Y. Rha, J. Stephenson, B. C. Schultes, P. Monroe, G. S. Eckhardt, L. A. Hammond, T. L. Whiteside, C. F. Nicodemus, J. M. Cermak, et al. Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity Ann. Onc., December 1, 2004; 15(12): 1825 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, L. Huang, and D. Kufe MUC1 Oncoprotein Activates the FOXO3a Transcription Factor in a Survival Response to Oxidative Stress J. Biol. Chem., October 29, 2004; 279(44): 45721 - 45727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Lillehoj, H. Kim, E. Y. Chun, and K. C. Kim Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L809 - L815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higuchi, T. Orita, K. Katsuya, Y. Yamasaki, K. Akiyama, H. Li, T. Yamamoto, Y. Saito, and M. Nakamura MUC20 Suppresses the Hepatocyte Growth Factor-Induced Grb2-Ras Pathway by Binding to a Multifunctional Docking Site of Met Mol. Cell. Biol., September 1, 2004; 24(17): 7456 - 7468. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Rahn, Q. Shen, B. K. Mah, and J. C. Hugh MUC1 Initiates a Calcium Signal after Ligation by Intercellular Adhesion Molecule-1 J. Biol. Chem., July 9, 2004; 279(28): 29386 - 29390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Raina, S. Kharbanda, and D. Kufe The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 Fibroblasts J. Biol. Chem., May 14, 2004; 279(20): 20607 - 20612. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Levi, D S Klimstra, N V Adsay, A Andea, and O Basturk MUC1 and MUC2 in pancreatic neoplasia J. Clin. Pathol., May 1, 2004; 57(5): 456 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higuchi, T. Orita, S. Nakanishi, K. Katsuya, H. Watanabe, Y. Yamasaki, I. Waga, T. Nanayama, Y. Yamamoto, W. Munger, et al. Molecular Cloning, Genomic Structure, and Expression Analysis of MUC20, a Novel Mucin Protein, Up-regulated in Injured Kidney J. Biol. Chem., January 16, 2004; 279(3): 1968 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wen, T. C. Caffrey, M. J. Wheelock, K. R. Johnson, and M. A. Hollingsworth Nuclear Association of the Cytoplasmic Tail of MUC1 and {beta}-Catenin J. Biol. Chem., September 26, 2003; 278(39): 38029 - 38039. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, Y. Li, J. Ren, H. Kuwahara, and D. Kufe Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative Stress J. Biol. Chem., September 12, 2003; 278(37): 35458 - 35464. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Andrechek, M. A. Laing, A. A. Girgis-Gabardo, P. M. Siegel, R. D. Cardiff, and W. J. Muller Gene Expression Profiling of Neu-induced Mammary Tumors from Transgenic Mice Reveals Genetic and Morphological Similarities to ErbB2-expressing Human Breast Cancers Cancer Res., August 15, 2003; 63(16): 4920 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Kohlgraf, A. J. Gawron, M. Higashi, J. L. Meza, M. D. Burdick, S. Kitajima, D. L. Kelly, T. C. Caffrey, and M. A. Hollingsworth Contribution of the MUC1 Tandem Repeat and Cytoplasmic Tail to Invasive and Metastatic Properties of a Pancreatic Cancer Cell Line Cancer Res., August 15, 2003; 63(16): 5011 - 5020. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, W.-h. Yu, J. Ren, W. Chen, L. Huang, S. Kharbanda, M. Loda, and D. Kufe Heregulin Targets {gamma}-Catenin to the Nucleolus by a Mechanism Dependent on the DF3/MUC1 Oncoprotein Mol. Cancer Res., August 1, 2003; 1(10): 765 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hinojosa-Kurtzberg, M. E. V. Johansson, C. S. Madsen, G. C. Hansson, and S. J. Gendler Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G853 - G862. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ren, Y. Li, and D. Kufe Protein Kinase C delta Regulates Function of the DF3/MUC1 Carcinoma Antigen in beta -Catenin Signaling J. Biol. Chem., May 10, 2002; 277(20): 17616 - 17622. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gonzalez-Guerrico, E. G. Cafferata, M. Radrizzani, F. Marcucci, D. Gruenert, O. H. Pivetta, R. R. Favaloro, R. Laguens, S. V. Perrone, G. C. Gallo, et al. Tyrosine Kinase c-Src Constitutes a Bridge between Cystic Fibrosis Transmembrane Regulator Channel Failure and MUC1 Overexpression in Cystic Fibrosis J. Biol. Chem., May 3, 2002; 277(19): 17239 - 17247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |